frankeidson.com – Our Orlando, Florida pharmaceutical litigation and defective drug attorneys are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers. We have handled many lawsuits involving potentially harmful pharmaceuticals (including claims involving Reglan® and Avandia®).

Product Description

Written by transcriptionists for transcriptionists, this drug reference lets you quickly locate the correct spelling and capitalization of more than 27,000 brand-name and generic drugs. It includes the corresponding uses of those drugs, cross-referencing of brand names to generics, and the usual methods of administration (e.g., capsule, IV, cream). To help you avoid errors, it also contains the indications of approved drugs and standard dosages.

• Over 27,000 brand-name and generic drugs are included, with dosage forms, investigational drug names, chemotherapy protocols, trademarked dosage forms, drug categories/classes, and almost 2,000 medicinal herbs and natural remedies.
• Pharmaceutical information is organized specifically for the medical transcriptionist, allowing you to correctly determine the drug being transcribed and confirm related information.
• Sound-alike “ear” icon helps you confirm the correct drug when similar names exist, increasing your accuracy and confidence.
• Appendices offer useful information at a glance, including sound-alikes, the most prescribed drugs, therapeutic drug levels, and abbreviations used with medications and dosages.

• Updated drug information ensures accuracy and timeliness, with new drugs added, obsolete drugs removed, and appropriate changes made.

Saunders Pharmaceutical Word Book 2010

Product Description

This digital document is an article from Bioresearch Monitoring Alert, published by Thomson Gale on July 1, 2005. The length of the article is 646 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Pharma firms need to get hip to HIPAA, particularly concerning CROs and PBMs, attorney says.(HIPAA)
Author: Diane West
Publication: Bioresearch Monitoring Alert (Newsletter)
Date: July 1, 2005
Publisher: Thomson Gale
Volume: 5 Issue: 7 Page: 2

Distributed by Thomson Gale

Pharma firms need to get hip to HIPAA, particularly concerning CROs and PBMs, attorney says.(HIPAA): An article from: Bioresearch Monitoring Alert